FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Victor Goldmacher

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Physiology

Cell Survival

Procedures

Co-author Network

Publications

TOP 3
Naomi Pode-Shakked; Sara Pri-Chen; Eithan Rom-Gross; Rachel Shukrun; Amos Simon; Peter Tsvetkov; Sarit Bahar; Edward Fridman; Victor S Goldmacher; Ronald S Goldstein; Orit Harari-Steinberg; Naftali Kaminski; Marcus Magister; Michal Mark-Danieli; Karen Meir; Yoram Mor; Benjamin Dekel
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
Robert Yongxin Zhao; Hans K Erickson; Victor S Goldmacher; John M Lambert; Barbara A Leece; Emily E Reid; Ravi V J Chari
Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
Robert Y Zhao; Sharon D Wilhelm; Charlene Audette; Gregory Jones; Barbara A Leece; Alexandru C Lazar; Victor S Goldmacher; Rajeeva Singh; Yelena Kovtun; Wayne C Widdison; John M Lambert; Ravi V J Chari
Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Victor Goldmacher (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Naomi Pode-Shakked; Sara Pri-Chen; Eithan Rom-Gross; Rachel Shukrun; Amos Simon; Peter Tsvetkov; Sarit Bahar; Edward Fridman; Victor S Goldmacher; Ronald S Goldstein; Orit Harari-Steinberg; Naftali Kaminski; Marcus Magister; Michal Mark-Danieli; Karen Meir; Yoram Mor; Benjamin Dekel
The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
EMBO molecular medicine 2013;5(1):18-37.
2012: Robert Yongxin Zhao; Hans K Erickson; Victor S Goldmacher; John M Lambert; Barbara A Leece; Emily E Reid; Ravi V J Chari
Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
Journal of medicinal chemistry 2012;55(2):766-82.
2011: Robert Y Zhao; Sharon D Wilhelm; Charlene Audette; Gregory Jones; Barbara A Leece; Alexandru C Lazar; Victor S Goldmacher; Rajeeva Singh; Yelena Kovtun; Wayne C Widdison; John M Lambert; Ravi V J Chari
Synthesis and evaluation of hydrophilic linkers for antibody-maytansinoid conjugates.
Journal of medicinal chemistry 2011;54(10):3606-23.
2011: Victor S Goldmacher; Yelena V Kovtun
Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells.
Therapeutic delivery 2011;2(3):397-416.
2010: Yelena V Kovtun; Charlene A Audette; Michele F Mayo; Gregory E Jones; Heather Doherty; Erin K Maloney; Hans K Erickson; Xiuxia Sun; Sharon Wilhelm; Olga Ab; Katharine C Lai; Wayne C Widdison; Brenda Kellogg; Holly Johnson; Jan Pinkas; Robert J Lutz; Rajeeva Singh; Victor S Goldmacher; Ravi V J Chari
Antibody-maytansinoid conjugates designed to bypass multidrug resistance.
Cancer research 2010;70(6):2528-37.
2009: Helena L A Vieira; Liliana Cunha; Victor S Goldmacher; Paula M Alves
The effect of the cell death suppressor vMIA on the production of a recombinant protein in the adenovirus-293 expression system.
Protein expression and purification 2009;64(2):179-84.
2008: Damien Arnoult; Anna Skaletskaya; Jérôme Estaquier; Cecilie Dufour; Victor S Goldmacher
The murine cytomegalovirus cell death suppressor m38.5 binds Bax and blocks Bax-mediated mitochondrial outer membrane permeabilization.
Apoptosis : an international journal on programmed cell death 2008;13(9):1100-10.
2008: Kenji Ishitsuka; Shiro Jimi; Victor S Goldmacher; Olga Ab; Kazuo Tamura
Targeting CD56 by the maytansinoid immunoconjugate IMGN901 (huN901-DM1): a potential therapeutic modality implication against natural killer/T cell malignancy.
British journal of haematology 2008;141(1):129-31.
2007: Anne-Laure Pauleau; Nathanael Larochette; F Giordanetto; Sebastian R Scholz; Delphine Poncet; Naoufal Zamzami; Victor S Goldmacher; Guido Kroemer
Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA.
Oncogene 2007;26(50):7067-80.
2007: Yelena V Kovtun; Victor S Goldmacher
Cell killing by antibody-drug conjugates.
Cancer letters 2007;255(2):232-40.
2007: Joseph A Reddy; Elaine Westrick; Hari K R Santhapuram; Stephen J Howard; Michael L Miller; Marilynn vetzel; Iontcho R Vlahov; Ravi V J Chari; Victor S Goldmacher; Christopher P Leamon
Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
Cancer research 2007;67(13):6376-82.
2006: Delphine Poncet; Anne-Laure Pauleau; Gyorgy Szabadkai; Angelo Vozza; Sebastian R Scholz; Morgane Le Bras; Jean-Jacques Briere; Abdelali JALIL; Ronan Le Moigne; catherine brenner; Gabriele Hahn; Ilka Wittig; Hermann Schägger; Christophe Lemaire; Katiuscia Bianchi; Sylvie Souquère; Gérard Pierron; Pierre Rustin; Victor S Goldmacher; Rosario Rizzuto; Ferdinando Palmieri; Guido Kroemer
Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA.
The Journal of cell biology 2006;174(7):985-96.
2006: Wayne C Widdison; Sharon D Wilhelm; Emily E Cavanagh; Kathleen R Whiteman; Barbara A Leece; Yelena V Kovtun; Victor S Goldmacher; Hongsheng Xie; Rita M Steeves; Robert J Lutz; Robert Zhao; Lintao Wang; Walter A Blättler; Ravi V J Chari
Semisynthetic maytansine analogues for the targeted treatment of cancer.
Journal of medicinal chemistry 2006;49(14):4392-408.
2006: Manohara S Mavinakere; Chad D Williamson; Victor S Goldmacher; Anamaris M Colberg-Poley
Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation.
Journal of virology 2006;80(14):6771-83.
2006: Hans K Erickson; Peter U Park; Wayne C Widdison; Yelena V Kovtun; Lisa M Garrett; Karen Hoffman; Robert J Lutz; Victor S Goldmacher; Walter A Blättler
Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.
Cancer research 2006;66(8):4426-33.
2006: Yelena V Kovtun; Charlene Audette; Yumei Ye; Hongsheng Xie; Mary F Ruberti; Sara J Phinney; Barbara A Leece; Thomas Chittenden; Walter A Blättler; Victor S Goldmacher
Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen.
Cancer research 2006;66(6):3214-21.
2005: Pierfrancesco Tassone; Paola Neri; Daniel R Carrasco; Renate Burger; Victor S Goldmacher; Robert Fram; Vidit Munshi; Masood Ahmad Shammas; Laurence Catley; Gary S Jacob; Salvatore Venuta; Kenneth C Anderson; Nikhil C Munshi
A clinically relevant SCID-hu in vivo model of human multiple myeloma.
Blood 2005;106(2):713-6.
2004: Erkan Baloglu; Michael L Miller; Elizabeth E Roller; Emily E Cavanagh; Barbara A Leece; Victor S Goldmacher; Ravi V J Chari
Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors.
Bioorganic & medicinal chemistry letters 2004;14(23):5885-8.
2004: Pierfrancesco Tassone; Victor S Goldmacher; Paola Neri; Antonella Gozzini; Masood Ahmad Shammas; Kathleen R Whiteman; Linda L Hylander-Gans; Daniel R Carrasco; Teru Hideshima; Reshma Shringarpure; Jialan Shi; Charles K Allam; John Wijdenes; Salvatore Venuta; Nikhil C Munshi; Kenneth C Anderson
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.
Blood 2004;104(12):3688-96.
2004: Michael L Miller; Elizabeth E Roller; Robert Y Zhao; Barbara A Leece; Olga Ab; Erkan Baloglu; Victor S Goldmacher; Ravi V J Chari
Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Journal of medicinal chemistry 2004;47(20):4802-5.
2004: Michael L Miller; Elizabeth E Roller; Xinyaun Wu; Barbara A Leece; Victor S Goldmacher; Ravi V J Chari; Iwao Ojima
Synthesis of potent taxoids for tumor-specific delivery using monoclonal antibodies.
Bioorganic & medicinal chemistry letters 2004;14(15):4079-82.
2004: Pierfrancesco Tassone; Antonella Gozzini; Victor S Goldmacher; Masood Ahmad Shammas; Kathleen R Whiteman; Daniel R Carrasco; Cheng Li; Charles K Allam; Salvatore Venuta; Kenneth C Anderson; Nikhil C Munshi
In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
Cancer research 2004;64(13):4629-36.
2004: Damien Arnoult; Laura M Bartle; Anna Skaletskaya; Delphine Poncet; Naoufal Zamzami; Peter U Park; Juanita Sharpe; Richard J Youle; Victor S Goldmacher
Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(21):7988-93.
2004: Delphine Poncet; Nathanael Larochette; Anne-Laure Pauleau; Marian Mellen; Abdelali JALIL; Pierre-Francois Cartron; François M Vallette; Céline Schnebelen; Laura M Bartle; Anna Skaletskaya; David Boutolleau; Jean-Claude Martinou; Victor S Goldmacher; Guido Kroemer; Naoufal Zamzami
An anti-apoptotic viral protein that recruits Bax to mitochondria.
The Journal of biological chemistry 2004;279(21):22605-14.
2003: A Louise McCormick; Anna Skaletskaya; Peter A Barry; Edward Mocarski; Victor S Goldmacher
Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses.
Virology 2003;316(2):221-33.
2002: Iwao Ojima; Xudong Geng; Xinyuan Wu; Chuanxing Qu; Christopher P Borella; Hongsheng Xie; Sharon D Wilhelm; Barbara A Leece; Laura M Bartle; Victor S Goldmacher; Ravi V J Chari
Tumor-specific novel taxoid-monoclonal antibody conjugates.
Journal of medicinal chemistry 2002;45(26):5620-3.
2002: Victor S Goldmacher
vMIA, a viral inhibitor of apoptosis targeting mitochondria.
Biochimie 2002;84(2-3):177-85.
2001: Helena L A Vieira; Anne-Sophie Belzacq; Delphine Haouzi; F Bernassola; Isabelle Cohen; Etienne Jacotot; Karine F Ferri; Chahrazed El Hamel; Laura M Bartle; G Melino; catherine brenner; Victor S Goldmacher; Guido Kroemer
The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal.
Oncogene 2001;20(32):4305-16.
2001: Anna Skaletskaya; Laura M Bartle; Thomas Chittenden; A L McCormick; Edward Mocarski; Victor S Goldmacher
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(14):7829-34.
2001: Wail A Hayajneh; Anamaris M Colberg-Poley; Anna Skaletskaya; Laura M Bartle; Marci M Lesperance; DG Contopoulos-Ioannidis; NL Kedersha; Victor S Goldmacher
The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains.
Virology 2001;279(1):233-40.
1999: Victor S Goldmacher; Laura M Bartle; Anna Skaletskaya; C A Dionne; NL Kedersha; CA Vater; J W Han; Robert J Lutz; S Watanabe; Ellen Cahir-McFarland; Elliott Kieff; Edward Mocarski; Thomas Chittenden
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(22):12536-41.
1997: C A Ladino; Ravi V J Chari; L A Bourret; NL Kedersha; Victor S Goldmacher
Folate-maytansinoids: target-selective drugs of low molecular weight.
International journal of cancer. Journal international du cancer 1997;73(6):859-64.
1997: J W Han; C A Dionne; NL Kedersha; Victor S Goldmacher
p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc.
Cancer research 1997;57(1):176-82.
1996: C A Vater; L M Bartle; Craig Dionne; T D Littlewood; Victor S Goldmacher
Induction of apoptosis by tamoxifen-activation of a p53-estrogen receptor fusion protein expressed in E1A and T24 H-ras transformed p53-/- mouse embryo fibroblasts.
Oncogene 1996;13(4):739-48.
1996: C Liu; B M Tadayoni; L A Bourret; K M Mattocks; S M Derr; W C Widdison; NL Kedersha; P D Ariniello; Victor S Goldmacher; J M Lambert; W A Blättler; R V Chari
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(16):8618-23.
1995: R O'Connor; C Liu; C A Ferris; B C Guild; B A Teicher; C Corvi; Y Liu; Robert J Arceci; Victor S Goldmacher; J M Lambert; W A Blättler
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors.
Blood 1995;86(11):4286-94.
1995: R V Chari; K A Jackel; L A Bourret; S M Derr; B M Tadayoni; K M Mattocks; S A Shah; C Liu; W A Blättler; Victor S Goldmacher
Enhancement of the selectivity and antitumor efficacy of a CC-1065 analogue through immunoconjugate formation.
Cancer research 1995;55(18):4079-84.
1995: C A Vater; L M Bartle; John Leszyk; J M Lambert; Victor S Goldmacher
Ricin A chain can be chemically cross-linked to the mammalian ribosomal proteins L9 and L10e.
The Journal of biological chemistry 1995;270(21):12933-40.
1995: C E Krek; C A Ladino; Victor S Goldmacher; W A Blättler; B C Guild
Expression and secretion of a recombinant ricin immunotoxin from murine myeloma cells.
Protein engineering 1995;8(5):481-9.
1995: C A Vater; K Reid; L M Bartle; Victor S Goldmacher
Characterization of antibody binding to cell surface antigens using a plasma membrane-bound plate assay.
Analytical biochemistry 1995;224(1):39-50.
1994: Victor S Goldmacher; L A Bourret; B A Levine; R A Rasmussen; M Pourshadi; J M Lambert; Kenneth C Anderson
Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.
Blood 1994;84(9):3017-25.
1994: S M Lehar; Jan Torleif Pedersen; R S Kamath; C Swimmer; Victor S Goldmacher; J M Lambert; W A Blättler; B C Guild
Mutational and structural analysis of the lectin activity in binding domain 2 of ricin B chain.
Protein engineering 1994;7(10):1261-6.
1994: M A Roguska; Jan Torleif Pedersen; C A Keddy; A H Henry; S J Searle; J M Lambert; Victor S Goldmacher; W A Blättler; Anthony R Rees; B C Guild
Humanization of murine monoclonal antibodies through variable domain resurfacing.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(3):969-73.
1994: A R Collinson; J M Lambert; Y Liu; C O'Dea; S A Shah; R A Rasmussen; Victor S Goldmacher
Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
International journal of immunopharmacology 1994;16(1):37-49.
1993: L E Bradbury; Victor S Goldmacher; Thomas F Tedder
The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):2915-27.
1993: S A Shah; J M Lambert; Victor S Goldmacher; H J Esber; J L Levin; V Chungi; A Zutshi; G M Braman; P D Ariniello; J A Taylor
Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
International journal of immunopharmacology 1993;15(6):723-36.
1993: Michael L Grossbard; J M Lambert; Victor S Goldmacher; N L Spector; J Kinsella; L Eliseo; F Coral; J A Taylor; W A Blättler; C L Epstein
Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):726-37.
1993: S A Shah; P M Halloran; C A Ferris; B A Levine; L A Bourret; Victor S Goldmacher; W A Blättler
Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models.
Cancer research 1993;53(6):1360-7.
1992: Michael L Grossbard; J M Lambert; Victor S Goldmacher; W A Blättler; Lee M Nadler
Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
Cancer research 1992;52(15):4200-7.
1992: Victor S Goldmacher; J M Lambert; W A Blättler
The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: evidence that the membrane binding and A-chain translocation activities of ricin cannot be separated.
Biochemical and biophysical research communications 1992;183(2):758-66.
1992: Victor S Goldmacher; P D Senter; J M Lambert; W A Blättler
Photoactivation of toxin conjugates.
Bioconjugate chemistry 1992;3(2):104-7.
1992: Michael L Grossbard; Arnold S Freedman; Jerome Ritz; F Coral; Victor S Goldmacher; L Eliseo; N Spector; K Dear; J M Lambert; W A Blättler
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
Blood 1992;79(3):576-85.
1992: R V Chari; B A Martell; J L Gross; S B Cook; S A Shah; W A Blättler; S J McKenzie; Victor S Goldmacher
Immunoconjugates containing novel maytansinoids: promising anticancer drugs.
Cancer research 1992;52(1):127-31.
1991: J M Lambert; Victor S Goldmacher; A R Collinson; Lee M Nadler; W A Blättler
An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.
Cancer research 1991;51(23 Pt 1):6236-42.
1991: J M Lambert; G McIntyre; M N Gauthier; D Zullo; V Rao; R M Steeves; Victor S Goldmacher; W A Blättler
The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides.
Biochemistry 1991;30(13):3234-47.
1989: Victor S Goldmacher; W A Blättler; J M Lambert; G McIntyre; J Stewart
Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
Molecular pharmacology 1989;36(5):818-22.
1989: W A Blättler; J M Lambert; Victor S Goldmacher
Realizing the full potential of immunotoxins.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1989;1(2):50-5.
1989: Victor S Goldmacher; C F Scott; J M Lambert; G D McIntyre; W A Blättler; A R Collnhson; J K Stewart; L D Chong; S Cook; H S Slayter
Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis.
Journal of cellular physiology 1989;141(1):222-34.
1988: Keith A Reimann; Victor S Goldmacher; J M Lambert; Laura V Chalifoux; S B Cook; S F Schlossman; Norman L Letvin
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.
The Journal of clinical investigation 1988;82(1):129-38.
1988: J M Lambert; W A Blättler; G D McIntyre; Victor S Goldmacher; C F Scott
Immunotoxins containing single-chain ribosome-inactivating proteins.
Cancer treatment and research 1988;37():175-209.
1987: S E Moroney; L J D'Alarcao; Victor S Goldmacher; J M Lambert; W A Blättler
Modification of the binding site(s) of lectins by an affinity column carrying an activated galactose-terminated ligand.
Biochemistry 1987;26(25):8390-8.
1987: C F Scott; Victor S Goldmacher; J M Lambert; J V Jackson; G D McIntyre
An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Journal of the National Cancer Institute 1987;79(5):1163-72.
1987: Victor S Goldmacher; J Anderson; M L Schulz; W A Blättler; J M Lambert
Somatic cell mutants resistant to ricin, diphtheria toxin, and to immunotoxins.
The Journal of biological chemistry 1987;262(7):3205-9.
1987: C F Scott; Victor S Goldmacher; J M Lambert; R V Chari; S Bolender; M N Gauthier; W A Blättler
The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.
Cancer immunology, immunotherapy : CII 1987;25(1):31-40.
1986: Victor S Goldmacher; N L Tinnel; B C Nelson
Evidence that pinocytosis in lymphoid cells has a low capacity.
The Journal of cell biology 1986;102(4):1312-9.
1986: Victor S Goldmacher; J M Lambert; A Y Young; J Anderson; N L Tinnel; M Kornacki; Jerome Ritz; W A Blättler
Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(1):320-5.
1985: Victor S Goldmacher; J Anderson; W A Blättler; J M Lambert; P D Senter
Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(6):3648-51.
1985: J M Lambert; P D Senter; A Yau-Young; W A Blättler; Victor S Goldmacher
Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins.
The Journal of biological chemistry 1985;260(22):12035-41.